The future of healthcare is
digital. We're building it.

Strategic Impact

Accelerating uptake of a newly launched respiratory therapy by precisely identifying patients with unmet needs and the physicians most able to reach them—resulting in measurable improvements in real‑world outcomes.

Business Objective

A life sciences client launched a novel treatment targeting patients with high unmet needs in the respiratory market. Success depended on understanding the true attainable patient population—both current and future—and on accurately identifying physicians with the greatest potential to influence patient access and adoption.

Key Challenges

• Limited visibility into patient sub‑cohorts with true medical unmet need
• Difficulty identifying high‑potential physicians treating the right patients at scale
• Inability to track early adoption and real‑world effectiveness beyond traditional rules‑based models

Insilicare Solution

Insilicare deployed its CORE Platform to systematically identify, profile, and prioritize eligible respiratory patients with unmet needs. Advanced analytics were applied to move beyond static rule‑based segmentation toward predictive patient and physician intelligence.

Patients were dynamically profiled using:

• Sub‑national geographic concentration
• Demographics and clinical characteristics
• Disease severity and treatment history
• Physician networks actively managing these patients

This enabled a precision‑driven view of both who the right patients were and where they were being treated.

Measurable Impact

• 78% precision in predicting patients with a high likelihood of asthma, compared with 41% using traditional rules‑based methodologies
• Clear identification of high‑value physician clusters aligned to target patient segments
• 11% reduction in uncontrolled disease status observed in a 9‑month real‑world follow‑up among patients initiated on the new therapy

Outcome

Insilicare enabled the client to move from broad targeting to precision engagement—maximising commercial effectiveness while demonstrably improving patient outcomes.

Strategic Impact

Strengthening launch readiness by delivering a single, scalable source of truth for patient and physician identification—driving sharper targeting decisions and greater organisational confidence.

Business Objective

The client sought to comprehensively assess both current and future cardiology patient populations and the physicians treating them. They required a systematic, privacy‑compliant solution capable of generating granular insights and scaling across multiple indications to support launch planning.

Key Challenges

• Data gaps and privacy constraints limiting access to actionable, patient‑level insights
• Difficulty identifying nuanced sub‑cohorts by indication and predicting future eligible patients
• Low confidence in targeting strategies driven by fragmented, non‑standardised approaches

Insilicare Solution

Insilicare positioned the CORE Platform as the client’s single point solution for advanced patient and physician finding. The platform unified disparate datasets, applied predictive methodologies, and delivered consistent insights across teams and functions.

Key capabilities included:

• Advanced identification of eligible and future‑eligible cardiology patients
• Dynamic HCP classification based on real‑world treating behaviour
• Scalable analytics supporting both brand and indication expansion

The platform was accessed by cross‑functional teams—including commercial, medical, and strategy—creating organisational alignment during a critical launch phase.

Measurable Impact

• Identification of 7× more eligible patients compared with prior approaches
• 24% reclassification of HCPs, reshaping the client’s understanding of their target universe
• Increased confidence in launch targeting and resource allocation decisions

Outcome

Insilicare transformed launch planning from assumption‑led to evidence‑driven—enabling the client to approach market entry with clarity, precision, and internal alignment.

Strategic Impact

Delivering fast, sub‑national insights to shape competitive strategy and proactively defend market position in a complex neurological disease area.

Business Objective

A neurology client commissioned Insilicare to conduct a competitive landscape assessment in the Multiple Sclerosis (MS) space. The goal was to generate actionable, regional insights that could inform brand positioning and support proactive defence of existing market share.

Key Challenges

• Fragmented data across healthcare settings, limiting longitudinal visibility of MS patients
• Difficulty tracking disease progression and treatment sequencing over time
• Limited understanding of real‑world treatment outcomes at a regional level

Insilicare Solution

Insilicare rapidly deployed the CORE Platform within four weeks, delivering a comprehensive and sub‑national view of the MS market.

CORE applications enabled:

• Detailed patient profiling through the Patient Insights app, including demographics, disease characteristics, and geographic distribution
• In‑depth analysis of treatment lines, switching patterns, and disease progression via the Treatment Journey module
• Clear visibility into regional variations shaping competitive dynamics

Measurable Impact

• Accelerated time‑to‑insight with platform deployment completed in under one month
• Robust sub‑national intelligence supporting tailored regional strategies
• Improved understanding of long‑term treatment patterns and outcomes within real‑world data constraints

Outcome

Insilicare empowered the client to move quickly and decisively—using data‑driven intelligence to refine competitive positioning and protect value in an evolving MS landscape.